| lncRNA name in article | Virus & Strain Name | Dosage & Time point | Cell line | Experiment Type | Fold change | Expression | P-value | Differential expression quantification method | Statistical method | Year | PubMed ID |
|---|---|---|---|---|---|---|---|---|---|---|---|
| TMEM161B-AS1 | Coxsackie virus B3 (CG strain of CVB3) | MOI = 0.5 ;
23 hr |
HeLa Human papillomavirus-related endocervical adenocarcinoma cells | Microarray | 2.12877 | Upregulation | 0.000287 | GeneSpring GX v11.5.1 software package (Agilent Technologies) | student's t test | 2019 | 31388922 |
| TMEM161B-AS1 | Coxsackie virus B3 (CG strain of CVB3) | MOI = 0.5 ;
23 hr |
HeLa Human papillomavirus-related endocervical adenocarcinoma cells | Microarray | 2.2655046 | Upregulation | 0.000287 | GeneSpring GX v11.5.1 software package (Agilent Technologies) | student's t test | 2019 | 31388922 |
* MOI :Multiplicity of infection , TCID :Tissue Culture Infectious Dose